Latest News

Non-invasive first trimester blood test reliably detects Down's syndrome and other genetic fetal abnormalities

New research has found that routine screening using a non-invasive test that analyzes fetal DNA in a pregnant woman's blood can accurately detect Down's syndrome and other genetic fetal abnormalities in the first trimester. The results suggest that the test is superior to currently available screening strategies and could reshape standards in prenatal testing.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • MS drug candidate shows new promise

  • Pathway that contributes to Alzheimer's disease revealed by research

  • Domestic violence likely more frequent for same-sex couples

  • Physical activity in older adults linked to brain white-matter integrity

  • Targeted radiation, drug therapy combo less toxic for recurrent head, neck cancers

  • 3-D shape processing in brain: New discovery on how objects, places are processed

  • Suicide Prevention Requires Access to Effective, Evidence-Based Treatment

  • Down Syndrome helps researchers understand Alzheimer's disease

  • Providing private mental health service to veterans: Hurdles, challenges, advice

  • Gun deaths twice as high among African-Americans as white citizens in US

  •